Fructose - Therapeutic use
Research News and Information

Monday, November 23, 2009

Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy.

8 Sep 2009 PURPOSE: Therapeutic hypothermia reduces mortality and neurologic impairment in neonates with hypoxic-ischemic encephalopathy. Topiramate exerts a neuroprotective effect in asphyxiated neonatal animal models. However, no studies have investigated ... Read more...

The effect of migraine prophylaxis on migraine-related resource use and productivity.

30 Aug 2009 In the US, it is estimated that up to 10% of men and 25% of women, particularly those aged 25-55 years, experience debilitating migraines, such that the condition presents an enormous economic burden for patients, health systems, employers and ... Read more...

Efficacy and tolerability of topiramate in pediatric migraine.

30 Aug 2009 About 5-10% of school-age children manifest migraine headaches. Treatment options for pediatric migraine are limited. Topiramate is approved for migraine prophylaxis in adults, but its use in children is limited. We retrospectively reviewed the ... Read more...

Latest indexed articles for 'Fructose - Therapeutic use'

These are the very latest articles for this heading:

• Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy. 8 Sep 2009
• The effect of migraine prophylaxis on migraine-related resource use and productivity. 30 Aug 2009
• Efficacy and tolerability of topiramate in pediatric migraine. 30 Aug 2009
• The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? 30 Aug 2009
• A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice. 27 Jul 2009
• Protective effects of topiramate against hyperoxic brain injury in the developing brain. 26 Jul 2009
• [The role of the neuromodulators in the preventive treatment of migraine] 29 Jun 2009
• Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study. 24 Jun 2009
• [Effectiveness of chemical, herbal and dietetic migraine prophylactis. An overview of randomized controlled double-blind studies] 9 Jun 2009
• 2009 Edward E Smissman Award. Pharmaceutical "gold" from neurostabilizing agents: topiramate and successor molecules. 9 Jun 2009
• Effects of topiramate on weight and metabolism in children with epilepsy. 6 Jun 2009
• Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. 4 Jun 2009
• [Pharmaceutical treatment of binge eating disorder] 30 May 2009
• ...And more benefit from sugar for vaccine relief. 30 May 2009
• A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder. 27 May 2009
• [Mood stabilizer in the psychopharmacotherapy of borderline personality disorder] 17 May 2009
• Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates--an exploratory study. 4 May 2009
• Treatment of alcohol-use disorders. 30 Apr 2009
• Review of topiramate: an antiepileptic for the treatment of alcohol dependence. 29 Apr 2009
• Treatment options for functional gastrointestinal disorders: from empiric to complementary approaches. 29 Apr 2009

See a longer list of these articles.

Technical information about 'Fructose'

Definition: A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.

Chemical name: Fructose

Registry Number: 30237-26-4

Descriptor UI: D005632

Alternative terms: Fructose; Levulose; Fleboplast Levulosa; Levulosa, Fleboplast; Levulosa Grifols; Grifols Brand of Fructose; Levulosado Vitulia; Ern Brand of Fructose; Levulosa Braun; Levulosado Braun; Braun Brand of Fructose; Levulosa Ife; Instituto Farmacologico Brand of Fructose; Levulosado Bieffe Medit; Bieffe Brand of Fructose; Apir Levulosa; Levulosa, Apir; Levulosa Mein; Fresenius Kabi Brand of Fructose; Levulosa Ibys; Plast Apyr Levulosa Mein; Levulosa Baxter; Levulosa; Baxter Brand of Fructose;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Sweetening Agents;

Tree Number: D09.546.359.250; D09.546.465.354;